Human APP/Protease Nexin II (Research Grade Aducanumab Biosimilar) Alexa Fluor 647-conjugated Antibody, R&D Systems™
Manufacturer: R&D Systems
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | FAB9710R100-Each-of-1 | In Stock | ₹ 41,607.50 |
FAB9710R100 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 41,607.50
GST (18%): ₹ 7,489.35
Total Price: ₹ 49,096.85
Antigen
APP
Classification
Monoclonal
Conjugate
Alexa Fluor 647
Formulation
Supplied 0.2 mg/mL in a saline solution containing BSA and sodium azide.
Host Species
Mouse
Purification Method
Protein A or G purified from cell culture supernatant
Primary or Secondary
Primary
Test Specificity
Detects human APP/Protease Nexin II based on Aducanumab therapeutic antibody. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Aducanumab. This product is for research use only.
Content And Storage
Protect from light.Do not freeze.12 months from date of receipt, 2 to 8°C as supplied.
Isotype
IgG1
Applications
Flow Cytometry
Clone
Hu15
Dilution
Flow Cytometry 0.25-1 ug/10^6 cells
Gene Alias
Amyloid beta, amyloid beta (A4) precursor protein-binding, family B, member 2, amyloid beta A4 precursor protein-binding family B member 2, Amyloid beta precursor protein, APP, beta Amyloid, Protease Nexin II
Immunogen
Human APP/Protease Nexin II
Quantity
100 μg
Gene ID (Entrez)
351.0
Target Species
Human
Form
Supernatant
Related Products
Description
- APP Monoclonal specifically detects APP in Human samples
- It is validated for Flow Cytometry.